Triple Hair Inc. is currently leading the study of new medication to prevent hair loss and stimulate hair growth in men.
Location: Canada
Total raised: $4M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.06.2024 | - | $4M | - |
Mentions in press and media 9
| Date | Title | Description |
| 19.06.2024 | NBIF Invest $200K in Triple Hair Inc. for their Phase III trial | Investment Manager Triple Hair Inc., a company specializing in the development of innovative treatments for androgenic alopecia, has closed a $4 million financing with a group of investors for their Phase III trial, backed by a $200,000 inv... |
| 03.06.2024 | Triple Hair Group Raises $4M in Funding | Triple Hair Group, a Montréal, Canada-based company which specializes in the development of innovative treatments for androgenic alopecia, raised $4M in funding. Backers included Prevail Partners, New Brunswick Innovation Fund and the Québe... |
| 19.06.2023 | Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S. | The Company strengthens the protection of its intellectual property in the world's largest market The additional protection will reduce the risk of infringement of its flagship product, thereby increasing the value of its patent portfolio /... |
| 19.06.2023 | Triple Hair Group consolide sa position d’innovateur et de leader d'industrie pour son médicament sur ordonnance Thérapie-07 aux États-Unis | La Société renforce la protection de sa propriété intellectuelle dans le plus grand marché mondial. Cette protection additionnelle permettra de réduire le risque de contrefaçon de son produit phare et d’accroître la valeur de son portefeuil... |
| 17.11.2022 | Triple Hair Group launches telehealth service for hair loss | The company also sells drug-free products for preventing hair loss and regaining hair density Androgenetic alopecia, more commonly known as male-pattern and female-pattern baldness, affects an estimated 50 million men and 30 million women i... |
| 07.12.2021 | Triple Hair Group, a Canadian biotechnology company specialized in the development of innovative treatments for alopecia, announces the launch of RIZN™ | MONTREAL, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce the launch of RIZNTM, a brand offer... |
| 07.12.2021 | Triple Hair Group, a Canadian biotechnology company specialized in the development of innovative treatments for alopecia, announces the launch of RIZN™ | MONTREAL, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce the launch of RIZNTM, a brand offer... |
| 29.11.2021 | Triple Hair Group adds further capital markets and life science expertise to board | MONTREAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce that Robert Y. Girard, who has 35-y... |
| - | Triple Hair | “Triple Hair is a clinical-stage Canadian biotechnology company specialized in the development of innovative treatments for alopecia. Prevent hair loss and boost hair growth.” |